Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung

About the company Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung

Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung, based in Zürich, is a company in Switzerland. Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung is active according to the commercial register. The company with the UID number CHE-112.206.974 was founded on 01/26/2005.

For Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung, a total of 24 official reports from the Swiss Official Gazette (SOGC) have been published on shab.help.ch since January 2007. You can see the latest publication by company Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung from 08/04/2025 on this link.

Purpose of the company Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung

The purpose of the company Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung in Zürich is as follows. The purpose of the foundation is to contribute to the improvement of the treatment of hemophilia and related disorders by providing therapies for people with hemophilia or related disorders, regardless of their origin, and by promoting and promoting projects and programs relating to the treatment of hemophilia and related disorders supported. The funds of the foundation are to be used in particular as follows: for the initiation or promotion of projects or programs at home and abroad to improve: understanding and commitment; the diagnosis and registration of hemophilia; the specialist knowledge required for the treatment and the infrastructure required for the treatment and; the education and empowerment of those directly and indirectly affected; the prevention of complications in the treatment of hemophilia and comorbidities. to award prizes for people who have performed special services in the Foundation's field of activity; to initiate and support congresses, meetings or similar events on hemophilia and related disorders and; for all or part of the cost of therapies for people with haemophilia or associated disorders in all countries in which such therapies are approved. The foundation is entitled to set up other foundations in Germany and abroad within the scope of its purpose and to pursue joint projects with domestic and foreign foundations or similar institutions with similar purposes. The foundation does not pursue profit-making or self-help purposes.

Translated by google.com

The company Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung in Zürich is listed on Yellowpages.swiss. Latitude and longitude coordinates for Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung are: 47.3768866 and 8.541694. The unique identification number of this portrait is CHE-112.206.974.

---

Data Source: Commercial register, SOGC, FSO
Last update on 04.08.2025

Which companies are available at the same address? In addition to Novo Nordisk Hämophilie & Hämoglobinopathien Stiftung, there are other active companies at the same address The Circle 32/38, 8058 Zürich. This includes the companies Novo Nordisk Pharma AG| Novo Nordisk Health Care AG.